GSK's Discovery Partnerships with Academia (DPAc) program is helping the pharma cast a wide net for early stage therapeutics beyond its core areas. So far this year, GSK has struck discovery deals with Vanderbilt University and The Hospital For Sick Children in severe obesity and cystic fibrosis, respectively.